Axon Enterprise, Inc. (NASDAQ:AXON) Holdings Raised by Siemens Fonds Invest GmbH

Siemens Fonds Invest GmbH raised its stake in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 219.7% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 2,481 shares of the biotechnology company's stock after buying an additional 1,705 shares during the quarter. Siemens Fonds Invest GmbH's holdings in Axon Enterprise were worth $1,475,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. New Wave Wealth Advisors LLC bought a new stake in Axon Enterprise during the 4th quarter valued at $40,000. Y.D. More Investments Ltd acquired a new position in shares of Axon Enterprise during the fourth quarter valued at $45,000. Stonebridge Financial Group LLC bought a new stake in shares of Axon Enterprise during the fourth quarter valued at about $53,000. GPS Wealth Strategies Group LLC lifted its holdings in Axon Enterprise by 74.1% in the fourth quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company's stock worth $56,000 after purchasing an additional 40 shares during the period. Finally, Berbice Capital Management LLC acquired a new stake in Axon Enterprise in the fourth quarter worth about $59,000. Institutional investors and hedge funds own 79.08% of the company's stock.

Axon Enterprise Price Performance

Shares of AXON traded down $7.37 during trading hours on Wednesday, hitting $735.38. 570,621 shares of the company were exchanged, compared to its average volume of 749,743. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The company has a market capitalization of $57.25 billion, a PE ratio of 190.02, a PEG ratio of 5.17 and a beta of 1.24. The firm has a fifty day simple moving average of $592.46 and a 200-day simple moving average of $598.92. Axon Enterprise, Inc. has a one year low of $273.52 and a one year high of $748.80.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last announced its earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 EPS for the quarter, beating the consensus estimate of $1.34 by $0.07. Axon Enterprise had a return on equity of 7.50% and a net margin of 15.37%. The business had revenue of $603.63 million during the quarter, compared to the consensus estimate of $585.67 million. During the same period in the prior year, the business posted $1.15 earnings per share. Axon Enterprise's revenue was up 31.3% compared to the same quarter last year. As a group, sell-side analysts predict that Axon Enterprise, Inc. will post 5.8 earnings per share for the current year.

Analyst Ratings Changes

A number of analysts have commented on the stock. The Goldman Sachs Group boosted their price target on shares of Axon Enterprise from $730.00 to $830.00 and gave the stock a "buy" rating in a research report on Wednesday, May 14th. Craig Hallum cut Axon Enterprise from a "buy" rating to a "cautious" rating in a report on Monday, March 10th. JMP Securities reaffirmed an "outperform" rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. Needham & Company LLC boosted their price objective on Axon Enterprise from $600.00 to $750.00 and gave the stock a "buy" rating in a research note on Thursday, May 8th. Finally, Northcoast Research lowered Axon Enterprise from a "buy" rating to a "neutral" rating in a report on Wednesday, February 19th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and ten have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $652.73.

Insiders Place Their Bets

In related news, Director Jeri Williams sold 307 shares of the company's stock in a transaction on Monday, March 17th. The stock was sold at an average price of $552.72, for a total transaction of $169,685.04. Following the transaction, the director now directly owns 1,627 shares of the company's stock, valued at approximately $899,275.44. The trade was a 15.87% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Patrick W. Smith sold 10,000 shares of the firm's stock in a transaction dated Monday, April 21st. The stock was sold at an average price of $540.99, for a total value of $5,409,900.00. Following the sale, the chief executive officer now owns 3,063,982 shares of the company's stock, valued at $1,657,583,622.18. The trade was a 0.33% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 25,064 shares of company stock worth $15,817,127. Company insiders own 4.40% of the company's stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.